Former Chief Legal Officer · Dianthus Therapeutics, Inc. (DNTH)

Thomas Beetham

A named executive officer of Dianthus Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,571,434

Salary $300,294Stock awards $0Bonus $523,490

FY2021: $1,894,380

2nd of 7 named executive officers at Dianthus Therapeutics by FY2023 total.

7 named officers on file for Dianthus Therapeutics, FY2023

Thomas Beetham’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • DNTH’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Dianthus Therapeutics’s whole pay program stands against its peers

  • Dianthus Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on DNTH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 11, 2024 (DEF 14A).

Free

Get Thomas Beetham’s full pay file as a PDF — free

More than this page: up to 10 years of Thomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Thomas Beetham compensation by year

Dianthus Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Dianthus Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2023
Salary$230,681$300,294
Bonus$0$523,490
Stock awards$0$0
Option awards$1,567,779$74,561
Non-equity incentive$92,000$0
Pension and deferred compensation$0$0
All other$3,920$673,089
Total$1,894,380$1,571,434

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dianthus Therapeutics, Inc. DEF 14A filed April 11, 2024, accession 0000950170-24-043693, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Dianthus Therapeutics, Inc. filed document, accession 0000950170-24-043693. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2024.

$1.9M
$1.6M
FY21
FY23
SalaryBonusNon-equity incentiveOption awardsAll other

Dianthus Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Stephen MahoneyFormer President, Chief Financial and Operating Officer$1,656,676
Thomas Beetham · this pageFormer Chief Legal Officer$1,571,434
Lisa OlsonFormer Chief Scientific Officer$1,128,013
Jason GardnerFormer President and Chief Executive Officer$667,649
Marino GarciaPresident and Chief Executive Officer$496,022
Simrat RandhawaChief Medical Officer$338,158
Ryan SavitzChief Financial Officer, Chief Business Officer and Treasurer$329,651

The full Dianthus Therapeutics compensation record

free company brief

This page is one person within Dianthus Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Dianthus Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Dianthus Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Beetham's compensation dossier · One-time report. No refunds.